Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B FISHER

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biochemistry|September 16, 1998
Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1Y M Zheng, M B Fisher, N Yokotani, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acidA J Sadeque, M B Fisher, K R Korzekwa, et al.
Chemico-Biological Interactions|May 5, 1998
Cytochrome P450-dependent desaturation of lauric acid: isoform selectivity and mechanism of formation of 11-dodecenoic acidX Guan, M B Fisher, D H Lang, et al.
Pharmacogenetics|February 24, 2001
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankM B Fisher, M Vandenbranden, K Findlay, et al.
Biochemistry|July 18, 2001
Active site characteristics of CYP4B1 probed with aromatic ligandsK R Henne, M B Fisher, K R Iyer, et al.
Chemical Research in Toxicology|March 1, 1993
Formation, characterization, and immunoreactivity of lysine thioamide adducts from fluorinated nephrotoxic cysteine conjugates in vitro and in vivoM B Fisher, P J Hayden, S A Bruschi, et al.
Biochemistry|March 17, 1999
Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin bindingR L Haining, J P Jones, K R Henne, et al.
Journal of Clinical Pharmacology|July 1, 1995
Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study GroupB Beller, T Bulle, R C Bourge, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1980
Myocardial revascularization in patients with chronic renal failureJ W Love, E J Jahnke, R B McFadden, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 28, 2014
Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interactionS J Brantley, B T Gufford, R Dua, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biochemistry|September 16, 1998
Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1Y M Zheng, M B Fisher, N Yokotani, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Human CYP2C9 and CYP2A6 mediate formation of the hepatotoxin 4-ene-valproic acidA J Sadeque, M B Fisher, K R Korzekwa, et al.
Chemico-Biological Interactions|May 5, 1998
Cytochrome P450-dependent desaturation of lauric acid: isoform selectivity and mechanism of formation of 11-dodecenoic acidX Guan, M B Fisher, D H Lang, et al.
Pharmacogenetics|February 24, 2001
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bankM B Fisher, M Vandenbranden, K Findlay, et al.
Biochemistry|July 18, 2001
Active site characteristics of CYP4B1 probed with aromatic ligandsK R Henne, M B Fisher, K R Iyer, et al.
Chemical Research in Toxicology|March 1, 1993
Formation, characterization, and immunoreactivity of lysine thioamide adducts from fluorinated nephrotoxic cysteine conjugates in vitro and in vivoM B Fisher, P J Hayden, S A Bruschi, et al.
Biochemistry|March 17, 1999
Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin bindingR L Haining, J P Jones, K R Henne, et al.
Journal of Clinical Pharmacology|July 1, 1995
Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study GroupB Beller, T Bulle, R C Bourge, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1980
Myocardial revascularization in patients with chronic renal failureJ W Love, E J Jahnke, R B McFadden, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 28, 2014
Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interactionS J Brantley, B T Gufford, R Dua, et al.
Pageof 2